Non-stimulant for adult ADHD moving into Phase 3 trials
Neurovance’s Phase 2b trial of the non-stimulant drug centanafadine SR has met both the primary and secondary endpoints. The research will move into Phase 3 trials in early 2017.
http://www.medicalnewstoday.com/releases/311974.php
Related Posts
-
The autistic brain: Boys vs. girls
Posted on Mar 22, 2022
-
Some neurons respond to singing but not other music
Posted on Mar 17, 2022
-
Poor score on simple memory test may be linked to Alzheimer’s biomarkers
Posted on Mar 15, 2022
-
Red dye 40 linked to ADHD
Posted on Mar 10, 2022
Tags
Share This
